The ESMO Breast Cancer Virtual Meeting took place on 23 – 24 May 2020. Experts in the field came together online to present the latest practice-changing data in breast cancer.

Hot topics at this year’s meeting included the rise of precision medicine, immunotherapy, and biomarkers. Updates from the latest clinical trials were received, including data from the CLEOPATRA, IMpassion130 and GELATO studies.

View all videos

ESMO Breast 2020

ESMO Breast 2020
23 – 24 May, 2020

It’s been 2 weeks since @myESMO World Congress on #GICancer ended but don’t worry, there’s still more expertly crafted medical content soon to be posted on 👉http://VJOncology.com👈
@VJOncology @WCGIC #WorldGI2020 #CRCsm #Pancsm #GCsm #OncoAlert

VIDEO: SAFIR02-IMMUNO: PDL1 copy number changes predicts checkpoint blockade inhibitor efficacy in mBC w/ Thomas Bachelot w/ @CLCCLeonBerard: http://ow.ly/5ZDZ50AuLdP

@VJOncology @myESMO #BCsm #VirtualMeeting #ESMOBreast20 #OncoAlert @OncoAlert #BreastCancer #ImmunoOnc

You think it’s dull to read tweets about the @myESMO 🤝 @OncoAlert 🚨 “Social Media & Virtual Meetings in the #COVID19 Era” survey?
Consider yourself lucky bc instead you can watch (‼️) #OncoAlert mastermind @weoncologists explain the whole thing in this (👇) @VJOncology video! https://twitter.com/vjoncology/status/1283072388209483777

VJ Oncology@VJOncology

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

#PYROTINIB EN #NSCLC AVANZADO HER2-MUTADO, PREVIO TRATAMIENTO CON #QUIMIOTERAPIA
https://www.esmo.org/oncology-news/pyrotinib-in-her2-mutated-advanced-nsclc-previously-treated-with-chemotherapy?hit=some

@Dunson30612519 @school_latin @GOncologia @ManuelDomine @MarianaBrandao0 @OPENoncology @susanahprieto @VJOncology @jillfeldman4 @dokter_onkologi @AnnaFaragoMD @myESMO https://twitter.com/myESMO/status/1282895118773686275

ESMO - Eur. Oncology@myESMO

Pyrotinib in HER2-mutated advanced #NSCLC previously treated with #chemotherapy: Promising antitumour activity & acceptable safety profile in #cancerpatients. A global, multicentre, randomised Ph3 III planned 🔎 http://ow.ly/4RcO50AwuT7 #oncologynews #cancerresearch #lcsm

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

Load More

ESMO Breast 2020

ESMO Breast 2020
23 – 24 May, 2020

The ESMO Breast Cancer Virtual Meeting took place on 23 – 24 May 2020. Experts in the field came together online to present the latest practice-changing data in breast cancer.

Hot topics at this year’s meeting included the rise of precision medicine, immunotherapy, and biomarkers. Updates from the latest clinical trials were received, including data from the CLEOPATRA, IMpassion130 and GELATO studies.

View all videos

It’s been 2 weeks since @myESMO World Congress on #GICancer ended but don’t worry, there’s still more expertly crafted medical content soon to be posted on 👉http://VJOncology.com👈
@VJOncology @WCGIC #WorldGI2020 #CRCsm #Pancsm #GCsm #OncoAlert

VIDEO: SAFIR02-IMMUNO: PDL1 copy number changes predicts checkpoint blockade inhibitor efficacy in mBC w/ Thomas Bachelot w/ @CLCCLeonBerard: http://ow.ly/5ZDZ50AuLdP

@VJOncology @myESMO #BCsm #VirtualMeeting #ESMOBreast20 #OncoAlert @OncoAlert #BreastCancer #ImmunoOnc

You think it’s dull to read tweets about the @myESMO 🤝 @OncoAlert 🚨 “Social Media & Virtual Meetings in the #COVID19 Era” survey?
Consider yourself lucky bc instead you can watch (‼️) #OncoAlert mastermind @weoncologists explain the whole thing in this (👇) @VJOncology video! https://twitter.com/vjoncology/status/1283072388209483777

VJ Oncology@VJOncology

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

#PYROTINIB EN #NSCLC AVANZADO HER2-MUTADO, PREVIO TRATAMIENTO CON #QUIMIOTERAPIA
https://www.esmo.org/oncology-news/pyrotinib-in-her2-mutated-advanced-nsclc-previously-treated-with-chemotherapy?hit=some

@Dunson30612519 @school_latin @GOncologia @ManuelDomine @MarianaBrandao0 @OPENoncology @susanahprieto @VJOncology @jillfeldman4 @dokter_onkologi @AnnaFaragoMD @myESMO https://twitter.com/myESMO/status/1282895118773686275

ESMO - Eur. Oncology@myESMO

Pyrotinib in HER2-mutated advanced #NSCLC previously treated with #chemotherapy: Promising antitumour activity & acceptable safety profile in #cancerpatients. A global, multicentre, randomised Ph3 III planned 🔎 http://ow.ly/4RcO50AwuT7 #oncologynews #cancerresearch #lcsm

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter